Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)

Journal of Pain and Symptom Management - Netherlands
doi 10.1016/j.jpainsymman.2019.06.020
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Correction To: Efficacy and Safety of Duloxetine and Pregabalin in Iranian Patients With Diabetic Peripheral Neuropathic Pain: A Double-Blind, Randomized Clinical Trial

Journal of Diabetes and Metabolic Disorders
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

A Randomized Trial of Pregabalin in Patients With Neuropathic Pain Due to Spinal Cord Injury

Neurology
Neurology
2013English

Efficacy of Pregabalin in Post-Traumatic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

Journal of Neurology
Neurology
2018English

Tapering Off Long-Term Opioid Therapy in Chronic Non-Cancer Pain Patients: A Randomized Clinical Trial

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2018English

A Randomized Controlled Trial of Ketorolac for Prevention of Headache Related to Electroconvulsive Therapy

Pain Studies and Treatment
2013English

Meta-Analysis of Duloxetine vs. Pregabalin and Gabapentin in the Treatment of Diabetic Peripheral Neuropathic Pain

BMC Neurology
MedicineNeurology
2009English

Double-Blind, Randomized, Controlled, Crossover Trial of Pregabalin for Neurogenic Claudication

Neurology
Neurology
2014English

Methadone vs. Morphine SR for Treatment of Neuropathic Pain: A Randomized Controlled Trial and the Challenges in Recruitment

Canadian Journal of Pain
2019English

Endogenous Analgesic Effect of Pregabalin: A Double-Blind and Randomized Controlled Trial

European Journal of Pain
MedicineAnesthesiologyPain Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy